News

Gladstone in the News October 6, 2020

Doudna Inc.: How Cal Scientist Created a Biotech Startup Engine

San Francisco Business Times—As Scribe Therapeutics Inc., the latest company founded by Senior Investigator Jennifer Doudna, PhD, announced that it landed a deal with Biogen Inc., Gladstone President Deepak Srivastava, MD, commented on the importance of CRISPR-based biotech companies for medicine and agriculture and on Doudna’s drive as a scientist.

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing

Gladstone in the News September 4, 2020

Bay Area Researchers Explain “Concerning” Effects of COVID-19 on Human Hearts

ABC7 News—As sports teams and colleges consider restarting the athletics season, Senior Investigator Todd McDevitt, PhD, and Gladstone President and Cardiologist Deepak Srivastava, MD, express concern that damage to the heart caused by SARS-CoV-2 infection could put athletes at risk for serious heart problems even if they only experienced mild COVID-19 symptoms.

Gladstone Experts COVID-19 Cardiovascular Disease McDevitt Lab Srivastava Lab

Gladstone in the News June 27, 2020

A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys

The New York Times—Gladstone President Deepak Srivastava, MD, and Senior Investigator Jennifer Doudna, PhD, comment on a recent report of the successful use of novel CRISPR technology to lower cholesterol and triglyceride levels in monkeys.

Gladstone Experts Heart Failure Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing Disease Models

Article May 8, 2020

Roddenberry Foundation Donates $1 Million to Support Gladstone COVID-19 Research

This generous gift will support Gladstone scientists who are pivoting their ongoing work to help fight the COVID-19 pandemic.

Donor Stories COVID-19 Roddenberry Stem Cell Center Srivastava Lab

Gladstone in the News April 7, 2020

Tackling Heart Disease

The Stem Cell Podcast—Gladstone President Deepak Srivastava describes his work using human induced pluripotent stem cells to investigate the gene networks that dictate cell fate decisions, and how this research could lead to therapeutics for congenital heart disease and heart failure. He also describes the importance of stem cell research in fighting the COVID-19 pandemic.

Gladstone Experts COVID-19 Heart Failure Congenital Heart Disease Cardiovascular Disease Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Article February 24, 2020

Tackling Heart Disease: It Takes a Team

Gladstone researchers are collaborating to solve cardiovascular diseases using new technologies.

Gladstone Experts Research (Publication) Heart Failure Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Virology Bruneau Lab Conklin Lab Krogan Lab

Article February 24, 2020

Two Gladstone Discoveries Are STAT Madness Finalists

Why should athletes and sports fans have all the fun in March?

Gladstone Experts Institutional News Huang Lab Srivastava Lab

Gladstone in the News February 24, 2020

Here Are the Contenders for STAT Madness 2020. Voting Begins March 2.

STAT—Two Gladstone studies have been selected to participate in STAT Madness—a March Madness-style competition for scientific papers. Voting begins March 2, 2020.

Gladstone Experts Huang Lab Srivastava Lab

Video February 20, 2020

Aging: Progress with Rejuvenation and Regeneration

Aging is the single greatest risk factor for developing Alzheimer’s disease, Parkinson’s disease, and other brain diseases.

Gladstone Experts Cardiovascular Disease Neurological Disease Finkbeiner Lab McDevitt Lab Srivastava Lab Aging

Video February 17, 2020

Embracing Disruptive Technologies to Accelerate Science Overcoming Disease

From penicillin to organ transplants, so many important discoveries have dramatically changed healthcare and medicine over the past decades. But what’s really behind all this progress?

Gladstone Experts Research (Publication) Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab Yamanaka Lab

Gladstone in the News January 24, 2020

CRISPR-Cas9: The Era of Genome Editing

France 24—On France 24, Gladstone President Deepak Srivastava explains CRISPR technology and the potential is has to cure disease.

Gladstone Experts Srivastava Lab

Article January 17, 2020

Gladstone Joins a $5.7 Million Initiative Focused on Single Ventricle Heart Defects

Funds will support five top research institutions to accelerate scientific discoveries and development of treatments for single ventricle heart defects.

Grants News Release Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab Srivastava Lab

Gladstone in the News December 23, 2019

Trump Administration Ethics Board to Review Fetal Tissue Studies

Bloomberg Law—Gladstone President Deepak Srivastava comments in Bloomberg Law on the Trump Administration’s plan to implement a fetal tissue ethics review board. Srivastava states that a once-a-year review board will hold up important medical research.

Gladstone Experts Srivastava Lab

Video December 13, 2019

Evolution of Research

Gladstone started as a single institute in 1979 but has since grown to four institutes which use cutting-edge technology to tackle cardiovascular, neurological, and immunological diseases.

History Cardiovascular Disease Data Science and Biotechnology Neurological Disease Virology Greene Lab Mahley Lab Mucke Lab Pollard Lab Srivastava Lab

Article December 13, 2019

$13 Million Grant to Probe the Genome of Heart Cells

Team of six laboratories will combine expertise in heart development and -omics technology to probe genome activity and organization in heart cells.

Grants News Release Heart Failure Bruneau Lab Conklin Lab Krogan Lab Pollard Lab Srivastava Lab